BeStock  
Stocks › NRIX

Nurix Therapeutics NRIX

US equityMarket cap rank #2661Biotechnology
$22.88 −$0.11 (-0.48%)
Pre-market · Oct 6, 7:30 am ET · After hours $22.88 0.00%
Open$22.81
Prev close$22.99
Day range$22.43 – $23.31
Volume1.01M
Market cap$2.37B
P/E (TTM)–
Dividend yield–

NRIX Stock News

Headlines matching Nurix Therapeutics or the NRIX ticker, most recent first.

  • Needham Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $34Market news · 4 Aug 2026
  • RBC Capital Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $36Market news · 10 Aug 2026
  • Jefferies Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $45Market news · 8 Jul 2026
  • Morgan Stanley Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $38Market news · 28 Jul 2026
  • Morgan Stanley Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $38Market news · 28 Jul 2026
  • UBS Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $31Market news · 22 Jul 2026
  • Wells Fargo Maintains Nurix Therapeutics(NRIX.US) With Hold Rating, Maintains Target Price $25Market news · 14 Jul 2026
  • Mizuho Securities Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $34Market news · 13 Jul 2026
  • A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $28 to $40Market news · 11 Jul 2026
  • BTIG Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $32Market news · 1 Jul 2026
  • Analysts Offer Insights on Healthcare Companies: Coya Therapeutics, Inc. (COYA), Nurix Therapeutics (NRIX) and Immunic (IMUX)TipRanks · 9 Jun 2026
  • A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $25 to $45Market news · 9 Jun 2026
  • Oppenheimer Initiates Nurix Therapeutics(NRIX.US) With Buy Rating, Announces Target Price $28Market news · 29 Jun 2026
  • Stifel Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $34Market news · 15 Jun 2026
  • J.P. Morgan Maintains Nurix Therapeutics(NRIX.US) With Buy RatingMarket news · 12 Jun 2026

Discussion

No comments yet — be the first to weigh in on NRIX.

Leave a comment

Scroll to Top